Related Experiment Video

Updated: Mar 2, 2026

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms
11:36

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms

Published on: May 29, 2020

3.5K

Diagnostic approach to autoimmune hepatitis

Paolo Muratori1, Marco Lenzi1, Fabio Cassani1

  • 1a Center for the Study and Treatment of Autoimmune Diseases of the Liver and Biliary System , Policlinico di Sant'Orsola, University of Bologna , Bologna , Italy.

Expert Review of Clinical Immunology
|May 9, 2017
PubMed

Insights

Diagnosing autoimmune hepatitis (AIH) remains challenging due to the absence of specific markers. A comprehensive evaluation of clinical, biochemical, immunological, and histological factors is crucial for accurate AIH diagnosis.

Area of Science:

  • Hepatology
  • Immunology
  • Internal Medicine

Background:

  • Autoimmune hepatitis (AIH) is a chronic liver inflammation that can lead to cirrhosis and liver failure without treatment.
  • Current diagnostic methods for AIH lack specific and reliable markers, complicating clinical practice.

Purpose of the Study:

  • To review the clinical expression, histological features, serological and genetic profiles of AIH.
  • To discuss differential diagnosis and overlap with other autoimmune liver diseases.

Main Methods:

  • Systematic Medline search of published literature over the last 10 years.
  • Keywords used: autoimmune hepatitis, diagnosis.
  • Inclusion of personal clinical experience.

Main Results:

  • AIH diagnosis relies on a combination of clinical, biochemical, immunological, and histological data.
  • Despite research, simple and reliable diagnostic markers for AIH are still lacking.
  • Differentiating AIH from other liver diseases and autoimmune conditions remains complex.

Conclusions:

  • Accurate diagnosis of autoimmune hepatitis is challenging and requires integrating multiple data types.
  • Further research is needed to identify specific biomarkers for AIH.
  • Hepatologists face significant challenges in diagnosing AIH confidently.
Abstract

Keywords:
Autoimmune hepatitisanti smooth muscle antibodiesantinuclear antibodiesautoantibodieshypergammaglobulinemiainterface hepatitisliver kidney microsome type 1pattern

More Related Videos

Simultaneous Distinction of Monospecific and Mixed DFS70 Patterns During ANA Screening with a Novel HEp-2 ELITE/DFS70 Knockout Substrate10:05

Simultaneous Distinction of Monospecific and Mixed DFS70 Patterns During ANA Screening with a Novel HEp-2 ELITE/DFS70 Knockout Substrate

Published on: January 17, 2018

37.4K
The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice09:03

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

Published on: February 3, 2012

19.9K

Related Concept Videos

Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
388
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
2.9K
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
244